Top Markets
Coin of the day
Alliance Pharma plc Alliance Pharma plc

Alliance Pharma plc

APH
Pozycja w akcjach #13762
Alliance Pharma plc is a pharmaceutical firm with an expansive global reach,... Alliance Pharma plc is a pharmaceutical firm with an expansive global reach, conducting business across Europe, the Middle East, Africa, the Asia Pacific region, China, and the Americas. The company's core activities involve sourcing, promoting, and distributing a diverse array of consumer healthcare items and prescribed medications. It currently manages the marketing rights for approximately 80 different products within these categories. Additionally, its offerings extend to medical devices, dietary supplements, and cosmetic goods. Notable brands within its portfolio include Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen. Founded in 1996, Alliance Pharma plc maintains its corporate base in Chippenham, United Kingdom.
Cena akcji
$0.85814713
Ostatnia synchronizacja: 2025-05-14
Kapitalizacja rynkowa
$463.40M
Zmiana (1 dzień)
-2.52%
Zmiana (1 rok)
0.00%
Kraj
GB
Handel Alliance Pharma plc (APH)

Kategoria

EPS dla Alliance Pharma plc (APH)
EPS na dzień December 2024 TTM: $-0.03
Według najnowszych raportów finansowych i ceny akcji firmy Alliance Pharma plc, obecny EPS (TTM) wynosi $-0.03. Na koniec roku 2023 firma miała EPS w wysokości $-0.08, spadek w porównaniu do do EPS z roku 2022, który wynosił $0.00.
Historia EPS dla Alliance Pharma plc od 2001 do 2026
EPS na koniec każdego roku
Rok EPS Zmień
2026 (TTM) $-0.03 -16.67%
2024 $-0.03 -67.95%
2023 $-0.08 -3,814.29%
2022 0.00 -88.65%
2021 $0.02 -12.32%
2020 $0.02 -66.88%
2019 $0.06 35.53%
2018 $0.05 -42.96%
2017 $0.08 73.47%
2016 $0.05 -30.66%
2015 $0.07 38.66%
2014 $0.05 -21.96%
2013 $0.06 8.02%
2012 $0.06 4.27%
2011 $0.06 -8.77%
2010 $0.06 60.42%
2009 $0.04 69.91%
2008 $0.02 -157.22%
2007 $-0.04 -726.98%
2006 $0.01 -18.18%
2005 $0.01 -116.96%
2004 $-0.05 109.22%
2002 $-0.02 -401.39%
2001 $0.01 0.00%
EPS dla podobnych firm lub konkurentów